Fharmazon vs Reina | 68–43 | 61.26% |
Fharmazon vs Jin | 48–46 | 51.06% |
Fharmazon vs Kazuya | 46–36 | 56.10% |
Fharmazon vs King | 35–31 | 53.03% |
Fharmazon vs Bryan | 33–25 | 56.90% |
Fharmazon vs Jun | 37–15 | 71.15% |
Fharmazon vs Lili | 36–15 | 70.59% |
Fharmazon vs Steve | 34–13 | 72.34% |
Fharmazon vs Clive | 28–16 | 63.64% |
Fharmazon vs Heihachi | 18–23 | 43.90% |
Fharmazon vs Lidia | 18–20 | 47.37% |
Fharmazon vs Paul | 19–18 | 51.35% |
Fharmazon vs Hwoarang | 17–20 | 45.95% |
Fharmazon vs Law | 18–17 | 51.43% |
Fharmazon vs Xiaoyu | 17–18 | 48.57% |
Fharmazon vs Devil Jin | 13–21 | 38.24% |
Fharmazon vs Nina | 16–17 | 48.48% |
Fharmazon vs Dragunov | 16–16 | 50.00% |
Fharmazon vs Lee | 19–13 | 59.38% |
Fharmazon vs Azucena | 18–14 | 56.25% |
Fharmazon vs Eddy | 20–12 | 62.50% |
Fharmazon vs Yoshimitsu | 15–16 | 48.39% |
Fharmazon vs Asuka | 13–14 | 48.15% |
Fharmazon vs Victor | 6–21 | 22.22% |
Fharmazon vs Lars | 15–10 | 60.00% |
Fharmazon vs Alisa | 10–13 | 43.48% |
Fharmazon vs Claudio | 6–15 | 28.57% |
Fharmazon vs Feng | 9–10 | 47.37% |
Fharmazon vs Leo | 7–10 | 41.18% |
Fharmazon vs Jack-8 | 11–5 | 68.75% |
Fharmazon vs Kuma | 8–7 | 53.33% |
Fharmazon vs Raven | 4–5 | 44.44% |
Fharmazon vs Panda | 5–2 | 71.43% |
Fharmazon vs Shaheen | 4–1 | 80.00% |
Fharmazon vs Leroy | 2–3 | 40.00% |
Fharmazon vs Zafina | 2–1 | 66.67% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.